Previous Article | Next Article ![]()
J Virol, April 1998, p. 3432-3435, Vol. 72, No. 4
Retroviral Genetics Section, ABL Basic
Research Program, National Cancer Institute-Frederick Cancer
Research and Development Center, Frederick, Maryland
21702,1 and
Department of
Microbiology and Immunology, Emory University School of Medicine,
Atlanta, Georgia 303222
Received 19 August 1997/Accepted 12 December 1997
A retroviral Env molecule consists of a surface glycoprotein (SU)
complexed with a transmembrane protein (TM). In turn, these complexes
are grouped into oligomers on the surfaces of the cell and of the
virion. In the case of murine leukemia viruses (MuLVs), the SU moieties
are polymorphic, with SU proteins of different viral isolates directed
towards different cell surface receptors. During maturation of the
released virus particle, the 16 C-terminal residues of TM (the R
peptide or p2E) are removed from the protein by the viral protease;
this cleavage is believed to activate the membrane-fusing potential of
MuLV Env. We have tested the possibility that different MuLV Env
proteins in the same cell can interact with each other, both physically
and functionally, in mixed oligomers. We found that coexpressed Env
molecules can be precipitated out of cell lysates by antiserum which
reacts with only one of them. Furthermore, they can evidently cooperate
with each other: if one Env species lacks the R peptide, then it can
apparently induce fusion if the SU protein of the other Env species
encounters its cognate receptor on the surface of another cell. This
functional interaction between different Env molecules has a number of
implications with respect to the mechanism of induction of membrane
fusion, for the genetic analysis of Env function, and for the design of targeted retroviral vectors for gene therapy.
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Evidence for Cooperation between Murine Leukemia
Virus Env Molecules in Mixed Oligomers

*
Corresponding author. Mailing address: Retroviral
Genetics Section, ABL-Basic Research Program, NCI-Frederick Cancer
Research and Development Center, P.O. Box B, Bldg. 535, Rm. 211, Frederick, MD 21702. Phone: (301) 846-1361. Fax: (301) 846-7146. E-mail: rein{at}ncifcrf.gov.
Present address: Vaccine Bioprocessing Research and Development,
Merck and Company, West Point, PA 19486.
This article has been cited by other articles:
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|